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through 1) the similar antibody used in the G1/G2 ELISA assay,
F-78, binding to a repetitive epitope exposed twice on G1 and G2
or, 2) by BC-3 detecting the aggrecanase-generated N-terminal
374ARGSVI sequence.
Results: Induction of cartilage degradation ex vivo, resulted in 10
fold elevated aggrecanase fragments (374ARGSVI-G2) (P=0.02)
and 9 fold increased total aggrecan release (G1/G2) (P=0.02),
compared to that of vehicle control. Total aggrecan levels in
RA patients were signiﬁcantly decreased from 824.8±31 ng/ml
in healthy controls to 570.5±30 ng/ml, corresponding to an
approximate 31% decrease (P<0.0001). Western blot analysis
for total aggrecan showed one strong band detected at 10 kDa,
and weaker bands at 25 and 45 kDa in both healthy controls
and RA patients. With regards to aggrecanase activity, only one
strong band in RA patients of 45 kDa was detected.
Conclusions: This study is the ﬁrst to characterize different
aggrecan fragments in human serum. We clearly demonstrate
that total aggrecan levels are lowered in RA patients. In align-
ment, RA patients had highly elevated aggrecanase-mediated
aggrecan degradation, providing a rationale for the decreased
aggrecan levels. These data may provide a new diagnostic tool
for monitoring joint-destruction in RA patients, and allow for early
assessment of response to treatment prior to that of traditional
radiographic techniques.
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Purpose: The present study measures the effects of metallopro-
teases on human articular cartilage. Supernatants from diges-
tions with these enzymes were analyzed via proteomics methods
to characterize post-translational modiﬁcations of cartilage pep-
tides, to determine speciﬁc cartilage protein cleavage sites of
different metalloproteases to better understand their selectivities,
and to measure release of peptides that may serve as useful
biomarkers of cartilage degradation. The metalloproteases uti-
lized in this study have been reported to be overexpressed and
active in arthritic cartilage, so determination of their substrates
and products may lead to a better understanding of their po-
tential role in disease and to identiﬁcation of new targets and
biomarkers of cartilage degradation.
Methods: Human articular cartilage was digested by addition
of exogenous metalloproteases, including MMP-2, -3, -8, -9, -
12, -13, ADAMTS-4, and ADAMTS-5, and proteolyzed peptide
products were identiﬁed by proteomics methods using mass
spectrometry.
Results: Complete sequences of peptides, including N- and
C-termini and post-translational modiﬁcations were determined.
Abundant peptides originating from collagen types I, II, and III,
biglycan, prolargin, ﬁbromodulin, ﬁbronectin, decorin, cartilage
oligomeric matrix protein, cartilage intermediate layer protein,
megakaryocyte stimulating factor, mimecan, aggrecan, and lu-
mican were identiﬁed after metalloprotease digestion. Speciﬁc
collagen type II peptide biomarkers, including those containing
the 3/4 – 1/4 cleavage site and those containing the Helix-II
and CTX-II domains, were observed after release by selected
proteases.
Conclusions: this study identiﬁes many of the most abundant
metalloprotease cleavage products of human articular cartilage.
The list of peptides generated by these digestions provides in-
sights into the broad number of substrates susceptible to speciﬁc
metalloprotease proteolysis in diseased cartilage. Many of these
peptides are potential biomarkers of arthritis or of metallopro-
tease activity in articular cartilage. Further evaluation of many of
these peptides as biomarkers might be achieved by quantitation
in synovial ﬂuid, blood, or urine.
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Purpose: Collagen type II is the predominant collagen in articular
cartilage and is highly speciﬁc for this tissue. A biomarker of
crosslinked C-telopeptide fragments of type II collagen (CTX II)
has been used to assess severity and progression of cartilage
degradation in humans. The objectives of the current study were
to evaluate the effects of exercise and osteochondral (OC) injury
on concentrations of CTX II fragments in synovial ﬂuid (SF) and
serum of horses.
Methods: SF and serum samples were taken from 3 groups of
Thoroughbred racehorses: (1) rested horses (n=40), (2) exer-
cised horses: group 1 horses had the same joints sampled after
4-7 months of race training (n=40) and (3) OC injured horses:
racehorses that had arthroscopic surgery for removal of OC frag-
ments resulting from racing injury (n=44). From group 1 and 2
horses, SF was obtained from 20 metacarpophalangeal (MCP),
Figure 1. Comparison of SF to serum CTX II concentrations (SF:serum) in
rested, exercised, and OC injured horses. A. MCJ - middle carpal joint; B. RCJ
- radiocarpal joint; C. MCP/MTP - metacarpophalangeal/metatarsophalangeal
joint.
